| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 12/26/1995 | US5478557 Probiotic for control of salmonella |
| 12/26/1995 | CA1337840C Amides of teicoplanin compounds |
| 12/21/1995 | WO1995034676A1 Population of cells enriched for myeloid and/or lymphoid progenitors and methods of making and using |
| 12/21/1995 | WO1995034671A1 Complementary adenoviral vector systems and cell lines |
| 12/21/1995 | WO1995034670A2 Recombinant aav genome encoding immunodeficiency virus protein |
| 12/21/1995 | WO1995034669A2 Retroviral gene therapy vectors and therapeutic methods based thereon |
| 12/21/1995 | WO1995034638A1 Methods for in vivo t cell activation by antigen-pulsed dendritic cells |
| 12/21/1995 | WO1995034572A1 THE PRODUCTION OF HEMOGLOBIN HAVING A δ-LIKE GLOBIN |
| 12/21/1995 | WO1995034310A1 Medicament base |
| 12/21/1995 | WO1995034309A1 Base for a medicament and a medicament based thereon (variants) |
| 12/21/1995 | WO1995034202A1 Methods for reducing hyperacute rejection of xenografts |
| 12/21/1995 | WO1995032731A3 Immunogenic pharmaceuticals |
| 12/21/1995 | WO1995030761A3 Methods of in vivo gene delivery |
| 12/21/1995 | WO1995020660A3 Immunization by inoculation of dna transcription unit |
| 12/21/1995 | CA2576396A1 Adeno-associated virus materials and methods |
| 12/21/1995 | CA2192660A1 Methods for reducing hyperacute rejection of xenografts |
| 12/21/1995 | CA2192655A1 Methods for in vivo t cell activation by antigen-pulsed dendritic cells |
| 12/21/1995 | CA2192066A1 The production of hemoglobin having a .delta.-like globin |
| 12/21/1995 | CA2191845A1 Retroviral gene therapy vectors and therapeutic methods based thereon |
| 12/20/1995 | EP0687911A2 Methods for assaying endotoxin concentration |
| 12/20/1995 | EP0687673A1 Oxazole derivatives as antitumoral agents |
| 12/20/1995 | EP0687184A1 Recombinant adenoviruses and use thereof in gene therapy for treating eye diseases |
| 12/20/1995 | EP0687180A1 Methods for detection and treatment of individuals having abnormal cells expressing hla-a2/tyrosinase peptide antigens |
| 12/20/1995 | EP0529032B1 Process for the continuous extraction of peat and apparatus for carrying out the process |
| 12/20/1995 | EP0462269B1 Cell encapsulating method and apparatus |
| 12/20/1995 | CN1113439A Syrup and its preparation |
| 12/20/1995 | CN1030528C Human placenta collagen and preparation thereof |
| 12/19/1995 | US5476659 Killing; particularly lymphocytic leukemia |
| 12/19/1995 | CA2016297C Device and method for depletion of the leucocyte content of blood and blood components |
| 12/19/1995 | CA1337760C Antibacterial and antitumor agents ll-e33288e-i and ll-e33288e-br, with processes and intermediates for producing said agents |
| 12/15/1995 | CA2151635A1 Antitumoral Compounds |
| 12/14/1995 | WO1995033997A1 Alpha b crystallin for use in diagnosis and therapy of auto-immune diseases in particular multiple sclerosis |
| 12/14/1995 | WO1995033855A1 Isolated nucleic acid molecule which codes for a tumor rejection antigen precursor, and uses thereof |
| 12/14/1995 | WO1995033840A1 Recombinant viruses, preparation and use thereof in gene therapy |
| 12/14/1995 | WO1995033823A1 Methods for selectively stimulating proliferation of t cells |
| 12/14/1995 | WO1995033821A1 Three-dimensional cartilage cultures |
| 12/14/1995 | WO1995033488A1 Method of preventing aggregation of various substances upon rehydration or thawing and compositions obtained thereby |
| 12/14/1995 | WO1995033484A1 Method for treating and preventing atherosclerosis |
| 12/14/1995 | WO1995033480A1 Pigment epithelium-derived factor: characterization, genomic organization and sequence of the pedf gene |
| 12/14/1995 | WO1995033470A1 Composition for dental use comprising krill enzyme |
| 12/14/1995 | DE4412794A1 Verfahren zur Herstellung von dendritischen Zellen, so erhaltene Zellen und Behälter zur Durchführung dieses Verfahrens A process for the preparation of dendritic cells thus obtained cells and container for carrying out this method |
| 12/14/1995 | CA2704083A1 Pigment epithelium-derived factor: characterization, genomic organization and sequence of the pedf gene |
| 12/14/1995 | CA2192468A1 Alpha b crystallin for use in diagnosis and therapy of auto-immune diseases in particular multiple sclerosis |
| 12/14/1995 | CA2192332A1 Composition for dental use comprising krill enzyme |
| 12/14/1995 | CA2192064A1 Three-dimensional cartilage cultures |
| 12/14/1995 | CA2191728A1 Isolated nucleic acid molecule which codes for a tumor rejection antigen precursor, and uses thereof |
| 12/14/1995 | CA2191586A1 Methods for selectively stimulating proliferation of t cells |
| 12/13/1995 | EP0686396A1 Enteral composition containing native micellar casein |
| 12/13/1995 | EP0686154A1 Novel use as anti-inflammatory agents for bis-heterocyclic compounds and pharmaceutical compositions thereof |
| 12/13/1995 | EP0686039A1 Method of enhancing immune response to oral vaccines |
| 12/13/1995 | CN1113265A Method for preparation of snake wine |
| 12/13/1995 | CN1113244A Novel process |
| 12/13/1995 | CN1113125A Giant salamander nutrient health-care product |
| 12/12/1995 | US5475001 Receptor tyrosine kinase inhibitory; anticarcinogenic agent |
| 12/12/1995 | US5474932 Prophylaxis and treatment of bacterial infections |
| 12/12/1995 | US5474890 Method for inducing the acrosome reaction in human and animal spermatozoa |
| 12/12/1995 | US5474771 Inhibits T cell activation of B cells ; binds to epitope |
| 12/12/1995 | US5474547 Parkinson disease, epilepsy |
| 12/09/1995 | CA2151117A1 A process for producing a thiol protease inhibitor derived from a microorganism belonging to the genus aspergillus |
| 12/07/1995 | WO1995033062A2 Method for introducing foreign matter into higher eukaryotic cells |
| 12/07/1995 | WO1995033061A1 Method for introducing nucleic acid in higher eukaryotic cells |
| 12/07/1995 | WO1995033060A1 Method of cancer treatment by p53 protein control |
| 12/07/1995 | WO1995033053A1 Hepatitis c virus asialoglycoproteins |
| 12/07/1995 | WO1995033046A1 Lactobacillus strains of human origin, their compositions and uses thereof |
| 12/07/1995 | WO1995032740A1 Transformed human hepatoma cell line which releases insulin |
| 12/07/1995 | WO1995032734A1 New methods and compounds for the selective modulation of antigen-specific t-cell responsiveness |
| 12/07/1995 | WO1995032731A2 Immunogenic pharmaceuticals |
| 12/07/1995 | WO1995032729A1 Short-term anti-cd3 stimulation of lymphocytes to increase their in vivo activity |
| 12/07/1995 | WO1995032722A1 Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof |
| 12/07/1995 | WO1995032721A1 Cellular factors that regulate the expression of genes encoding proteins involved in cholesterol homeostasis |
| 12/07/1995 | WO1995032720A1 Composition for treating gastrointestinal disorders |
| 12/07/1995 | WO1995032709A1 Activation of growth factors by matrix vesicles |
| 12/07/1995 | WO1995032627A1 Use of fas ligand to suppress lymphocyte-mediated immune responses |
| 12/07/1995 | WO1995032624A1 Methods and apparatus for cryopreservation of cells |
| 12/07/1995 | DE4418965A1 Transfection of eukaryotic cells with nucleic acid |
| 12/07/1995 | CA2191762A1 Method for introducing nucleic acid in higher eukaryotic cells |
| 12/07/1995 | CA2191467A1 Cellular factors that regulate the expression of genes encoding proteins involved in cholesterol homeostasis |
| 12/07/1995 | CA2190963A1 Method for introducing foreign matter into higher eukaryotic cells |
| 12/07/1995 | CA2190265A1 Hepatitis c virus asialoglycoproteins |
| 12/07/1995 | CA2188812A1 New methods and compounds for the selective modulation of antigen-specific t-cell responsiveness |
| 12/07/1995 | CA2187731A1 Activation of growth factors by matrix vesicles |
| 12/06/1995 | EP0685556A1 Aqueous vehicle for keeping non-autonomous animal cells, particularly bovine sperm cells, alive outside their natural environment |
| 12/06/1995 | EP0685491A2 Process for producing albumin preparation |
| 12/06/1995 | EP0685481A2 Alkaloids from mappia foetida, the use thereof and formulations containing them |
| 12/06/1995 | EP0684867A1 Blood filter and method of manufacturing filter |
| 12/06/1995 | EP0684866A1 Filtration media and device for filtering leukocytes |
| 12/06/1995 | EP0684864A1 Methods for characterizing complex filtration media |
| 12/06/1995 | EP0684842A1 Composition for use in the treatment of tumours and the immunization of humans and animals |
| 12/06/1995 | EP0684828A1 EXPANSION OF STEM CELLS IN LONG TERM BONE MARROW CULTURES BY NEUTRALIZATION OF TGF-$g(b) |
| 12/06/1995 | EP0684763A1 Method and apparatus for treating a body fluid |
| 12/06/1995 | EP0673259A4 A method for transplanting cells into the brain and therapeutic uses therefor. |
| 12/06/1995 | CN1112959A Lactobacillus used to enhance immunological functions |
| 12/06/1995 | CN1112928A Novel method for preparation and/or purification of clavulanic acid or pharmaceutical salt or ester of same |
| 12/06/1995 | CN1112838A Chinese proprietary for curing hepatitis |
| 12/06/1995 | CN1112836A Meicinal prepn. "Kexianling" for curing epilepsy |
| 12/06/1995 | CN1112831A Long lasting multi-function nutritive skin care liquid containing extract of snail and the mfg. method |
| 12/06/1995 | CN1112825A Minimizing trichomadesis with anti-fungus compound and halogeno-anti-bacteria compound |
| 12/06/1995 | CN1030430C Strengthening nutrition oral liquor containing blood of soft-shelled turtle, the prepn. method thereof |
| 12/05/1995 | US5472942 Anti-thrombins |
| 12/05/1995 | US5472867 Culturing the cells treated with monoclonal antibody in growth medium with hematopoietic growth factors and cytokines of leukin, interleukin, erythropoietin and stem cell growth factor |